Skip to content

Cardiovascular Evaluation Before Renal Transplantation

Cardiovascular Diagnostic Before Renal Transplantation: a Prospective Study to Assess Cardiovascular Morbidity Before Renal Transplantation and to Improve Standard Diagnostic Procedures.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01064674
Enrollment
100
Registered
2010-02-08
Start date
2009-12-31
Completion date
2010-09-30
Last updated
2010-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease, Coronary Artery Disease

Keywords

renal transplantation, cardiovascular morbidity, evaluation before renal transplantation

Brief summary

Due to rising importance of cardiovascular disease before and after renal transplantation we have changed our standard diagnostic procedure and perform stress echocardiography and myocardial scintigraphy. We would like to monitor these results and the outcome of our patients.

Detailed description

Chronic kidney disease is a well-known risk factor for cardiovascular disease. Patients waiting for a renal transplantation usually undergo an extensive diagnostic procedure to avoid complications after transplantation such as neoplasia or inflammation. In the past years, cardiovascular complications before and after renal transplantation have gained more attention. We therefore have changed our standard diagnostic procedure before renal transplantation and perform stress echocardiography and myocardial scintigraphy. Thus we would like to evaluate our new standard diagnostic procedure and observe the results of these diagnostic procedures as well as their impact on clinical outcome.

Interventions

Cardiovascular diagnostic standard procedure before renal transplantation using stress echocardiography and stress myocardial scintigraphy.

Sponsors

University Hospital Muenster
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* endstage renal disease * preparing for renal transplantation

Exclusion criteria

* children (\< 18 years) * women who are pregnant or nursing * patients who are also awaiting heart transplantation or have already a heart transplant * severe mental illness

Design outcomes

Primary

MeasureTime frame
cardiovascular morbidityone year

Countries

Germany

Contacts

Primary ContactBarbara Suwelack, MD
barbara.suwelack@ukmuenster.de00492518347540
Backup ContactViola Malyar, MD
viola.malyar@ukmuenster.de00492518347540

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026